Cannara Biotech: Top 10 Undervalued Drug Manufacturers Industry Stocks (LOVE)
Cannara Biotech is now ranked among the top 10 undervalued stocks in the Drug Manufacturers industry on the Toronto Stock Exchange or TSX Venture Exchange.
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
Drug Manufacturers: Major, global pharmaceutical manufacturers offering a broad and diverse line of drug and healthcare products; industry leaders that have made a significant commitment to the research and development of a long pipeline of drugs.
Stocks in this category are held primarily for capital appreciation.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| LFST | Lifeist Wellness | 0.06 | 0.21 | 0.15 (256.8%) | 41965 | 1.8 | 0.0 | 0.0 |
| VPH | Valeo Pharma | 0.04 | 0.12 | 0.07 (158.9%) | 28134 | 4.4 | 0.0 | 0.0 |
| AVNT | Avant Brands | 0.90 | 2.24 | 1.34 (149.1%) | 8882 | 9.4 | 0.0 | 0.0 |
| CANB | CanadaBis Cap | 0.05 | 0.12 | 0.07 (139.2%) | 50587 | 6.9 | 0.0 | 2.5 |
| ENTG | Entourage Health | 0.01 | 0.03 | 0.02 (106.3%) | 105516 | 4.6 | 0.0 | 0.0 |
| CWEB | Charlottes Web Holdings | 0.20 | 0.34 | 0.14 (67.8%) | 39363 | 31.4 | 0.0 | 0.0 |
| CRON | Cronos Group | 3.11 | 4.61 | 1.50 (48.1%) | 88399 | 1188.5 | 0.0 | 0.0 |
| LOVE | Cannara Biotech | 0.67 | 0.96 | 0.29 (44.0%) | 11554 | 61.3 | 0.0 | 11.2 |
| MDP | Medexus Pharma | 2.56 | 3.65 | 1.09 (42.5%) | 15706 | 62.6 | 0.0 | 46.2 |
| WEED | Canopy Gwth | 7.57 | 10.49 | 2.92 (38.5%) | 1669357 | 599.9 | 0.0 | 0.0 |
All data provided as of October 28, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
Cannara Biotech
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building.
Cannara Biotech is listed under LOVE on the TSX Venture Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
